U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07622173) titled 'Dry-Shield vs Rubber Dam During Fissure Sealant Placement' on May 26. Brief Summary: This r... Read More
U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07624266) titled 'Comparison of First and Second Capillary Blood Drops for Blood Glucose Measurement' on May 1... Read More
U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623369) titled 'A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors' on May 29. Brief Su... Read More
U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07622927) titled 'FOCUS Bipolar: Families Opening Conversations for Understanding Signs' on Feb. 21. Brief Su... Read More
U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623811) titled 'Efficacy and Safety of Acute Topical and Aromatic Essential Oil-Based Products for Cognitive... Read More
U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623772) titled 'Confident Moves Intervention Efficacy Trial: Obesity Care Settings' on May 21. Brief Summar... Read More
U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623733) titled 'Support Your Heart, Phase 1' on May 20. Brief Summary: This is a pilot feasibility study de... Read More
U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623707) titled 'A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic So... Read More
U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07624201) titled 'Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive Muscle-Invasi... Read More
U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07624175) titled 'Immunogenicity and Tolerability of Booster Typhoid Conjugate Vaccine (TCV) 5-6 Years After I... Read More